Oversold Stock Signal: PSTV
Report Date: 05-13-2022
Symbol: PSTV - Plus Therapeutics, Inc.
Sector:
Industry:
Oversold Stock Signal: PSTV
Plus Therapeutics, Inc. (PSTV)
4200 Marathon Blvd Ste 200
Austin, TEXAS 78756
Phone: 17372557194
Website: https://www.plustherapeutics.com
CEO: Dr. Marc Hedrick
NASDAQ, NASDAQ Capital Market
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium-186 NanoLiposome, a patented radiotherapy that targets central nervous system cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. It has a license agreement with NanoTx, Corp. to develop and commercialize NanoTx's glioblastoma treatment. The company was formerly known as Cytori Therapeutics, Inc. and changed its name to Plus Therapeutics, Inc. in July 2019. Plus Therapeutics, Inc. was founded in 1996 and is headquartered in Austin, Texas.